2023 Approvals

FDA Approves ZAVZPRET Nasal Spray for Rapid Relief of Acute Migraine Symptoms on March 2023

FDA Approves ZAVZPRET Nasal Spray for Rapid Relief of Acute Migraine Symptoms on March 2023

What is ZAVZPRET prescribed for?    ZAVZPRET is prescribed for the acute treatment of migraine with or without aura in adults. What is the name of the drug and what does it do?  Zavzpret (generic name: zavegepant), pronounced “zav-spret,” is a medication for adults suffering from migraine headaches, with or without a warning sensation (aura)...

FDA Approves SKYCLARYS to Aid Friedreich’s Ataxia Patients on February 28, 2023

FDA Approves SKYCLARYS to Aid Friedreich’s Ataxia Patients on February 28, 2023

What is SKYCLARYS  prescribed for?  SKYCLARYS is prescribed for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older. What is the name of the drug and what does it do?  SKYCLARYS is a medication for adults and teenagers aged 16 years and above who have Friedreich’s ataxia (FA).  FA is a rare genetic...

FDA Approves FILSPARI to Aid Kidney Health in IgA Nephropathy on February 2023

FDA Approves FILSPARI to Aid Kidney Health in IgA Nephropathy on February 2023

What is FILSPARI prescribed for?   FILSPARI is prescribed to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. What is the name of the drug and what does it do?  FILSPARI (generic name: sparsentan), pronounced “fil spah’ ree,” is a medicine that helps adults with a kidney condition called...

FDA Approval on February 16, 2023: LAMZEDE Breakthrough for Alpha-Mannosidosis Treatment

FDA Approval on February 16, 2023: LAMZEDE Breakthrough for Alpha-Mannosidosis Treatment

What is LAMZEDE prescribed for?    For the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. What is the name of the drug and what does it do?  LAMZEDE (generic name: velmanase alfa-tycv), pronouonced “lam-zed,” is a medicine made from human genes that helps treat the non-brain...

EXXUA: A Groundbreaking Step for Treating Major Depression Approved on September 22, 2023

EXXUA: A Groundbreaking Step for Treating Major Depression Approved on September 22, 2023

What is EXXUA prescribed for?   EXXUA is  prescribed to treat major depressive disorder in adults.  What is the name of the drug and what does it do? EXXUA, pronounced EKS-shoo-uh, (generic name: gepirone)  is a new medication approved by the FDA for treating adults with major depressive disorder (MDD).  This drug offers a new option...